Yan Leyfman and Raajit Rampal
Oct 28, 2024, 14:47
Yan Leyfman: The diagnosis and management of thrombotic risk in MPN by Raajit Rampal
Yan Leyfman, Co founder and executive director of MedNews Week, shared on LinkedIn:
“Great discussion about the diagnosis and management of thrombotic risk in MPN from Global Leader Dr. Raajit Rampal of Memorial Sloan Kettering Cancer Center at MSKCC‘s 2024 Updates in Thrombosis and Hemostasis.”
More posts featuring Yan Leyfman on oncodaily.com
Yan Leyfman MD, is the Co founder and executive director of MedNews Week. He is also the Medical correspondent at OncLive. He is also the Executive Committee Alejandro Aballay Member at Music Beats Cancer. He is a Clinical Researcher at Icahn School of Medicine at Mount Sinai. His research interests include oncology, Immunooncology, Cellular Therapy, and Immunotherapy.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19